ACOR Short Information Acorda Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	725,290
Total Actual Volume	4,154,622

Averages
Average Short Volume	36,265
Average Short Percentage	48.57%

Is there a ACOR Short Squeeze or Breakout about to happen?

See the ACOR Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-09-29	0.2611	0.2767	0.2974	0.2611	121,777	18,351	39.1296
2022-09-28	0.3	0.2911	0.322	0.2801	129,465	13,167	16.5178
2022-09-27	0.315	0.291	0.3245	0.29	82,825	20,923	46.7574
2022-09-26	0.286	0.3014	0.3244	0.2811	262,580	36,369	40.1238
2022-09-23	0.3201	0.2861	0.327	0.2861	287,988	87,388	51.7916
2022-09-22	0.3234	0.33	0.33	0.2766	1,055,722	105,226	55.4043
2022-09-21	0.33	0.31	0.346999	0.304	207,073	20,283	37.5966
2022-09-20	0.34	0.335	0.365899	0.33	301,544	28,021	48.6104
2022-09-19	0.34	0.3485	0.3779	0.324	155,839	39,787	72.8406
2022-09-16	0.3833	0.34	0.3998	0.34	190,632	28,839	47.4951
2022-09-15	0.4101	0.4	0.42	0.3964	265,548	14,236	22.9055
2022-09-14	0.4	0.403	0.4253	0.39	196,672	81,047	86.5776
2022-09-13	0.37	0.4	0.4159	0.37	140,756	70,405	80.1724
2022-09-12	0.42	0.4096	0.4222	0.3969	70,161	5,788	19.2593
2022-09-09	0.3988	0.414	0.4147	0.396	88,782	24,790	70.3242
2022-09-08	0.38	0.3988	0.4	0.375	77,282	18,300	56.9118
2022-09-07	0.378905	0.3749	0.3799	0.3621	117,273	17,958	35.5070
2022-09-06	0.3653	0.3725	0.41	0.3653	185,002	40,104	45.7119
2022-09-01	0.4054	0.3879	0.4081	0.3806	152,437	44,425	70.7123
2022-08-31	0.43	0.4062	0.43	0.4	65,264	9,883	27.0916

Stock Information

Acorda Therapeutics Inc. Company Name:

ACOR Stock Symbol:

NASDAQ Market:

Acorda Therapeutics Inc. Website:

Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...

ACOR - Acorda Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will be presenting at the H.C. Wainwright 24 th Annual Global Investment Conference on Monday, September 12 at 3 p.m. ET. The conference will be conduc...
ACOR - Acorda Therapeutics Enters into License Agreement with Asieris Pharmaceuticals

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China. Under the terms of the agreement, Acorda will receive an upf...
ACOR - Acorda Therapeutics Announces Resignation of Chief Operating Officer

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022. Ms. Sabella will be working in a strategic advisory role for early-stage biotechnology companies. “We are grateful...